JPRN-UMIN000005776已完成未知
Clinical study of autologous tumor lysate-pulsed dendritic cell therapy after resection of lung cancer - Clinical study of autologous tumor lysate-pulsed dendritic cell therapy after resection of lung cancer
Seta Clinic Fukuoka0 个研究点目标入组 8 人开始时间: 2011年6月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: (1)Pulmonary fibrosis or interstitial pneumonia, or history or predisposition of them (2)Serious drug allergy (3)Serious cardiac disease (4)Active autoimmune disease (5)Other cancers (6)Active infections (7)Positive for HIV or HTLV-1 (8)Other serious complications (9)Pregnant or lactating (10)Continuous systemic administration of steroids (11)Any reason why, in the opinion of the investigator, the patient should not participate.
研究者
相似试验
已完成
1 期
Clinical study of autologous tumor lysate-pulsed dendritic cell therapy for advanced colorectal cancer (Stage3, 4)colorectal cancer (Stage3, 4)JPRN-UMIN000005929Tomishiro Central Hospital15
Unknown
2 期
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal CancerNeoplasmsIntestinal NeoplasmsDigestive System NeoplasmsGastrointestinal DiseasesColorectal CancerNCT02202928Shenzhen Hornetcorn Bio-technology Company, LTD60
已完成
1 期
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.Metastatic MelanomaNCT02678741Elios Therapeutics, LLC26
招募中
不适用
Investigate the safety and efficacy of lymphoma immunotherapylymphomaACTRN12611000988954The First Teaching Hospital, Inner Mongolia Medical College30
已完成
1 期
se of stem cells for treatment of chronic kidney diseaseChronic Kidney Disease.Hypertensive renal diseaseIRCT201509031031N17Department of Regenerative Biomedicine, Cell Science Research Center, Royan Institute for Stem Cell10
